Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Stengel

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Medicinal Chemistry|November 26, 1993
Biphenylyl-substituted xanthones: highly potent leukotriene B4 receptor antagonistsJ S Sawyer, R F Baldwin, M J Sofia, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonistB D Gitter, R F Bruns, J J Howbert, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activityH E Shannon, M J Sheardown, F P Bymaster, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
The discovery of LY293111, a novel, potent and orally active leukotriene B4 receptor antagonist of the biphenylphenol classM J Sofia, P Floreancig, N Bach, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Medicinal Chemistry|November 26, 1993
Biphenylyl-substituted xanthones: highly potent leukotriene B4 receptor antagonistsJ S Sawyer, R F Baldwin, M J Sofia, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonistB D Gitter, R F Bruns, J J Howbert, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activityH E Shannon, M J Sheardown, F P Bymaster, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
The discovery of LY293111, a novel, potent and orally active leukotriene B4 receptor antagonist of the biphenylphenol classM J Sofia, P Floreancig, N Bach, et al.
Pageof 4